Bank of Montreal’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,173
| Closed | -$337K | – | 3965 |
|
|
2024
Q1 | $337K | Sell |
10,173
-2,364
| -19% | -$75.4K | ﹤0.01% | 2712 |
|
|
2023
Q4 | $421K | Buy |
+12,537
| New | +$355K | ﹤0.01% | 2633 |
|
|
2022
Q2 | – | Sell |
-3,613
| Closed | -$113K | – | 4178 |
|
|
2022
Q1 | $113K | Buy |
+3,613
| New | +$94.6K | ﹤0.01% | 3620 |
|
|
2021
Q4 | – | Sell |
-60,227
| Closed | -$1.76M | – | 3595 |
|
|
2021
Q3 | $1.76M | Buy |
+60,227
| New | +$1.45M | ﹤0.01% | 2144 |
|
|
2021
Q2 | – | Sell |
-8,438
| Closed | -$171K | – | 4057 |
|
|
2021
Q1 | $171K | Sell |
8,438
-9,264
| -52% | -$176K | ﹤0.01% | 3183 |
|
|
2020
Q4 | $299K | Buy |
17,702
+11,040
| +166% | +$146K | ﹤0.01% | 2998 |
|
|
2020
Q3 | $78K | Sell |
6,662
-2,873
| -30% | -$33.8K | ﹤0.01% | 3220 |
|
|
2020
Q2 | $76K | Sell |
9,535
-1,986
| -17% | -$13.3K | ﹤0.01% | 3224 |
|
|
2020
Q1 | $55K | Sell |
11,521
-11,125
| -49% | -$99.4K | ﹤0.01% | 2856 |
|
|
2019
Q4 | $205K | Buy |
22,646
+980
| +5% | +$7.96K | ﹤0.01% | 3147 |
|
|
2019
Q3 | $156K | Sell |
21,666
-115,452
| -84% | -$828K | ﹤0.01% | 3059 |
|
|
2019
Q2 | $1.09M | Buy |
137,118
+4,158
| +3% | +$49.2K | ﹤0.01% | 2029 |
|
|
2019
Q1 | $1.67M | Buy |
132,960
+26,484
| +25% | +$419K | ﹤0.01% | 1782 |
|
|
2018
Q4 | $2.12M | Buy |
106,476
+6,094
| +6% | +$141K | ﹤0.01% | 1490 |
|
|
2018
Q3 | $2.85M | Buy |
100,382
+76,073
| +313% | +$1.81M | ﹤0.01% | 1475 |
|
|
2018
Q2 | $511K | Sell |
24,309
-3,521
| -13% | -$66.6K | ﹤0.01% | 2331 |
|
|
2018
Q1 | $397K | Buy |
27,830
+3,913
| +16% | +$56K | ﹤0.01% | 2321 |
|
|
2017
Q4 | $294K | Buy |
23,917
+13,240
| +124% | +$187K | ﹤0.01% | 2519 |
|
|
2017
Q3 | $190K | Buy |
10,677
+197
| +2% | +$4.06K | ﹤0.01% | 2692 |
|
|
2017
Q2 | $266K | Buy |
10,480
+4,260
| +68% | +$102K | ﹤0.01% | 2509 |
|
|
2017
Q1 | $138K | Buy |
6,220
+6,077
| +4,250% | +$117K | ﹤0.01% | 2657 |
|
|
2016
Q4 | $3K | Sell |
143
-340
| -70% | -$6.7K | ﹤0.01% | 3826 |
|
|
2016
Q3 | $12K | Buy |
483
+340
| +238% | +$7.95K | ﹤0.01% | 3504 |
|
|
2016
Q2 | $3K | Buy |
+143
| New | +$1.96K | ﹤0.01% | 3840 |
|
|
2015
Q4 | – | Sell |
-37,200
| Closed | -$594K | – | 4275 |
|
|
2015
Q3 | $594K | Buy |
37,200
+27,200
| +272% | +$531K | ﹤0.01% | 1781 |
|
|
2015
Q2 | $195K | Buy |
+10,000
| New | +$186K | ﹤0.01% | 2423 |
|
Other funds holding EVH
RCM
EC
RSCM
EAM
Bank of Montreal's EVH Position: Q2 2024 in Review
Bank of Montreal sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 10,173 shares — an estimated $337K sold.
Bank of Montreal first reported a position in EVH in Q2 2015 and held it in 26 quarters. The position peaked at $2.85M in Q3 2018. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.
- Bank of Montreal reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
- Bank of Montreal sold 10,173 Evolent Health shares in Q2 2024, an estimated $337K.
- Bank of Montreal first reported a position in Evolent Health in Q2 2015 and held it in 26 quarters.
- Bank of Montreal's Evolent Health position peaked at $2.85M in Q3 2018.
- 243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.
Based on Bank of Montreal's 13F filing for Q2 2024, filed 14 Aug 2024.